DUBLIN–(BUSINESS WIRE)–The “Xiidra- Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering.
Xiidra Drug Insight, 2019 highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location.
The report covers the Global Market Assessment of the Xiidra covering the historical global sales and also provides the Xiidra sales estimation during the forecasted period (2019-2021). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Xiidra and emerging therapies in this space.
Scope
- A review of the Xiidra, based on information derived from company and industry-specific sources
- Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
- Coverage of the Drug Master Files and API Manufacturers by country
- Patent Expiry Timeline and Exclusivity Details
- Route of Synthesis of the API
- Forecasted Sales Figure from 2019-2021
- Market competition and emerging therapies
- SWOT Analysis
Reasons to Buy
- Establish a comprehensive understanding of Xiidra
- Access to drug`s API manufacturers details to devise API procurement strategy for generic development
- Plan developmental timelines around drug`s patents for the major markets – US and EU
- Understand Xiidra`s current and future growth through its historical and forecasted sales
- Identify and understand the current in-market competitors for the drug
- Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
- Identify and plan ahead for prospective emerging players and their products operating in the same space as the drug
- Identify opportunities in the same area as Xiidra with the SWOT analysis
Key Topics Covered
1. Report Introduction
2. Xiidra – Overview
- Product Description
- Route of Synthesis
- Mechanism of Action
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Adverse Reactions
- Regulatory Milestones by Region
- Deals and Partnerships
3. Product Details
4. Xiidra Sales Assessment
- Historical Sales
- Forecasted Sales
5. Patent Details
6. Global API Manufacturers Assessment
- Active Pharmaceutical Ingredient (API) Manufacturers by Country
- Active Pharmaceutical Ingredient (API) Manufacturers by Region
7. Market Competition
8. Emerging Therapies
- Product Description
- Research and Development
- Product Development Activities
9. SWOT Analysis
For more information about this report visit https://www.researchandmarkets.com/r/f0pmz1
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900